Ardelyx (ARDX) EBITDA Margin (2013 - 2026)
Ardelyx (ARDX) reported EBITDA Margin of 40.15% for Q1 2026, up 1542.0% on a YoY basis from 2.44% in Q1 2025, and down 14995.69% quarter-over-quarter from 0.27% in Q4 2025.
Ardelyx (ARDX) EBITDA Margin (2013 - 2026) Analysis & Trends
Ardelyx has reported EBITDA Margin for 12 years, with the latest figure at 40.15% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 1542.0% year-over-year to 40.15%; the trailing twelve-month figure through Mar 2026 stood at 18.15% (down 329.0% YoY), and the FY2025 full-year result was 15.09%, down 331.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 40.15%, down from 0.27% in the prior quarter.
- The five-year high for EBITDA Margin was 24.34% in Q4 2022, with the low at 6015.6% in Q1 2022.
- Historically, EBITDA Margin has averaged 477.53% across 5 years, with a median of 40.15% in 2026.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 551183 bps — and 2023, when it surged 578041 bps.
- Ardelyx's EBITDA Margin stood at 24.34% in 2022, then plunged by 439 bps to 82.58% in 2023, then soared by 105 bps to 3.89% in 2024, then sank by 107 bps to 0.27% in 2025, then slumped by 14996 bps to 40.15% in 2026.
- The last three EBITDA Margin figures came in at 40.15% (Q1 2026), 0.27% (Q4 2025), and 23.74% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -40.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.15% |
| Dec 31, 2025 | -0.27% |
| Sep 30, 2025 | -23.74% |
| Jun 30, 2025 | -19.59% |
| Mar 31, 2025 | -55.57% |
| Dec 31, 2024 | 3.89% |
| Sep 30, 2024 | -0.53% |
| Jun 30, 2024 | -22.58% |
| Mar 31, 2024 | -58.15% |
| Dec 31, 2023 | -82.58% |
| Sep 30, 2023 | 11.77% |
| Jun 30, 2023 | -77.51% |
| Mar 31, 2023 | -235.19% |
| Dec 31, 2022 | 24.34% |
| Sep 30, 2022 | -459.25% |
| Jun 30, 2022 | -1,067.26% |
| Mar 31, 2022 | -6,015.60% |
| Dec 31, 2021 | -3,522.16% |
| Sep 30, 2021 | -3,715.94% |
| Jun 30, 2021 | -3,440.82% |